The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-N-(4-fluoro-3-(trifluoromethyl)phenyl)-3-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)propanamide ID: ALA4476849
PubChem CID: 141764047
Max Phase: Preclinical
Molecular Formula: C24H18F4N4OS
Molecular Weight: 486.49
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(CCSc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1)Nc1ccc(F)c(C(F)(F)F)c1
Standard InChI: InChI=1S/C24H18F4N4OS/c25-20-8-4-16(13-19(20)24(26,27)28)30-23(33)10-12-34-17-6-7-18-21(31-32-22(18)14-17)9-5-15-3-1-2-11-29-15/h1-9,11,13-14H,10,12H2,(H,30,33)(H,31,32)/b9-5+
Standard InChI Key: PZPRLQXNZZEXAP-WEVVVXLNSA-N
Molfile:
RDKit 2D
34 37 0 0 0 0 0 0 0 0999 V2000
19.3977 -3.4902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1074 -3.0807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1045 -2.2581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3959 -1.8528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6897 -3.0812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6864 -2.2647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9088 -2.0155 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.4315 -2.6780 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.9141 -3.3366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8107 -1.8468 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
21.5199 -2.2528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2261 -1.8415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9353 -2.2474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6415 -1.8362 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.9384 -3.0646 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.6648 -4.1148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8661 -4.2880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6168 -5.0662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8184 -5.2359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5689 -6.0133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1185 -6.6193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9207 -6.4427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1664 -5.6655 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.3508 -2.2421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3510 -3.0594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0594 -3.4652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7665 -3.0539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7608 -2.2325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0518 -1.8303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4763 -3.4589 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
25.0638 -4.2851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0662 -5.0286 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
24.4036 -4.8268 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
25.7275 -4.8224 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
3 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
13 15 2 0
9 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
14 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
27 30 1 0
31 32 1 0
31 33 1 0
31 34 1 0
26 31 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 486.49Molecular Weight (Monoisotopic): 486.1137AlogP: 6.41#Rotatable Bonds: 7Polar Surface Area: 70.67Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 13.47CX Basic pKa: 4.59CX LogP: 5.58CX LogD: 5.58Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.23Np Likeness Score: -1.97
References 1. Liu X, Wang B, Chen C, Jiang Z, Hu C, Wu H, Zhang Y, Liu X, Wang W, Wang J, Hu Z, Wang A, Huang T, Liu Q, Wang W, Wang L, Wang W, Ren T, Li L, Xia R, Ge J, Liu Q, Liu J.. (2018) Discovery of (E)-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)propanamide (CHMFL-ABL-121) as a highly potent ABL kinase inhibitor capable of overcoming a variety of ABL mutants including T315I for chronic myeloid leukemia., 160 [PMID:30317026 ] [10.1016/j.ejmech.2018.10.007 ]